Repligen (RGEN) Cash & Current Investments (2010 - 2026)

Repligen (RGEN) has 17 years of Cash & Current Investments data on file, last reported at $986.4 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $986.4 million, up 41.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $986.4 million (up 41.48% YoY), and the FY2025 annual result was $767.6 million, up 1.32% from the prior year.
• Cash & Current Investments rose to $986.4 million in Q1 2026 per RGEN's latest filing, from $767.6 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $986.4 million in Q1 2026 and troughed at $573.4 million in Q3 2022.
• A 5-year average of $707.2 million and a median of $708.9 million in 2025 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2026: Cash & Current Investments dropped 18.77% in 2022, then surged 41.48% in 2026.
• A 5-year view of Cash & Current Investments shows it stood at $623.8 million in 2022, then gained by 20.45% to $751.3 million in 2023, then gained by 0.84% to $757.6 million in 2024, then grew by 1.32% to $767.6 million in 2025, then climbed by 28.5% to $986.4 million in 2026.
• Business Quant data shows RGEN's Cash & Current Investments at $986.4 million in Q1 2026, $767.6 million in Q4 2025, and $748.7 million in Q3 2025.